A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
about
Replicon RNA Viral Vectors as VaccinesVaccines for Epidemic Infections and the Role of CEPIThe broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.An Outbreak of Ebola Virus Disease in the Lassa Fever Zone.Vaccine platforms to control Lassa fever.Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment Viruses.DNA-launched live-attenuated vaccines for biodefense applications.Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge.A vaccine platform against arenaviruses based on a recombinant hyper-attenuated Mopeia virus expressing heterologous glycoproteins.Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.A Zika virus vaccine expressing premembrane-envelope-NS1 polyproteinUse of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig ModelCurrent research for a vaccine against Lassa hemorrhagic fever virusThe S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig ModelScreening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug LibraryNon-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever
P2860
Q28076639-AB522B00-64F6-4A23-B58F-4003C6AC96A1Q29224804-D0B87CBC-0B4E-4F09-93C3-965F62BE1CA7Q36146469-F1C82BA8-8D2D-4026-A595-26DBCC94BC29Q38378926-D09E423A-2A10-4DFD-AA12-7F89E04CA59EQ38823264-73C03002-ABC2-4096-91CA-8517633DF6FCQ40109981-4B084C10-4C99-4AD6-AAD7-1948DD9EAFD3Q40110791-A312DABD-4F47-41D6-BEFE-3DC75A11A784Q52586088-F7762D33-C479-4A31-A7EF-2086252588CEQ52625005-F6B4C6C7-9F6A-4031-B8D5-133AF8ABDBEDQ52723914-6693AD78-BCA1-48DC-8B03-0F00D32718DEQ55306089-4C91E988-4BF0-4A40-8F8E-83A58F0486FEQ56341869-34C9935D-C27F-4D6F-9538-45198F732265Q56576756-23473D3F-98F0-412D-B003-D360F79129B7Q56909960-76357437-01AA-4C80-B07A-2FBF67596503Q56913187-FC823EF2-C5D9-4465-BAA2-C05473C3D716Q56999457-315910E2-D449-4F85-86AD-A374ED2EF674Q57476548-C59BAC49-723D-42FC-A2EA-2EABD7C6B658
P2860
A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A recombinant vesicular stomat ...... ically distinct Lassa viruses.
@ast
A recombinant vesicular stomat ...... ically distinct Lassa viruses.
@en
type
label
A recombinant vesicular stomat ...... ically distinct Lassa viruses.
@ast
A recombinant vesicular stomat ...... ically distinct Lassa viruses.
@en
prefLabel
A recombinant vesicular stomat ...... ically distinct Lassa viruses.
@ast
A recombinant vesicular stomat ...... ically distinct Lassa viruses.
@en
P2093
P2860
P50
P1476
A recombinant vesicular stomat ...... ically distinct Lassa viruses.
@en
P2093
Elaine Haddock
Kyle Rosenke
Thomas Geisbert
P2860
P304
P356
10.1371/JOURNAL.PNTD.0003736
P407
P577
2015-04-17T00:00:00Z